MedTrace Logo

Atrial Fibrillation Stratification Based on the Arrhythmia Perpetuation Mechanisms

NCT04578275 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-04-20

No results posted yet for this study

Summary

Atrial fibrillation treatments have a limited efficacy and often cause long-term side effects. This study aims to develop and validate an ECGI system to risk stratification in patients with persistent AF, identifying the mechanisms responsible for the maintenance and the best treatment for ending it.

Conditions

Interventions

OTHER

diagnostic strategy using ECGI

Procedure: Drug treatment, CVE, Pulmonary vein ablation isolation according to treatment guidelines and investigators discretion. ECGI: customized body surface mapping (57 electrodes) at the inclusion in the study, after treatment assignment and prior to AF ablation procedure.

Sponsors & Collaborators

  • Universitat Politècnica de València

    collaborator OTHER

  • Felipe Atienza

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-18
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04578275 on ClinicalTrials.gov